US research university contributing optogenetics, neuroscience, and photobiology expertise to European consortia as a specialist third-party partner.
Michigan State University is a major US public research university that contributes specialized scientific expertise to European research consortia, primarily through researcher mobility (Marie Skłodowska-Curie fellowships) and as a third-party partner. Their H2020 contributions span photobiology and optogenetics in cyanobacteria, neuroscience imaging techniques, clinical pain research, and urban health mapping. As a non-EU institution, MSU typically provides complementary capabilities — advanced lab facilities, unique biological expertise, or access to US patient cohorts — that European consortia cannot source domestically.
Three projects — PHOTO-CY-APPs (optogenetics in cyanobacteria), CCMuPWA (corpus callosum inhibition via MRI-compatible optogenetics), and eMOTIONAL Cities (neurophysiology) — all involve light-based or imaging-based investigation of neural or biological systems.
PHOTO-CY-APPs focused specifically on photoprotection mechanisms in marine cyanobacteria, including Orange Carotenoid Protein and Phycobilisome regulation.
IMI-PainCare involved biomarkers, deep phenotyping, and patient-reported outcome measures for acute and chronic pain conditions including endometriosis and bladder pain syndrome.
AUTHENT-NET mapped food authenticity research networks across member states and established transnational standards for combating food fraud.
eMOTIONAL Cities (their largest funded project at EUR 845K) maps urban environments through neurophysiological and cognitive responses of inhabitants.
MSU's early H2020 involvement (2016–2018) was broad and exploratory, spanning food authenticity networks, multimedia forensics, and superconducting spintronics — with no clear thematic focus. From 2019 onward, a strong convergence toward neuroscience and optogenetics emerged, with projects on cyanobacterial photoprotection, corpus callosum imaging, and urban neurophysiology all sharing light-responsive biological systems or brain function as a common thread. This shift suggests MSU's H2020-active research groups consolidated around photobiology and neuroscience methods, moving away from the earlier food and materials science engagements.
MSU is increasingly focused on optogenetics, neuroimaging, and the intersection of biology with light-based technologies — future partners should look here rather than at their earlier food or materials work.
MSU never coordinates H2020 projects — all 8 participations are as partner or third party, consistent with their status as a non-EU institution that cannot lead Horizon projects. Five of eight projects are third-party roles, suggesting they are typically brought in for specific scientific contributions rather than deep consortium management. With 88 unique partners across 28 countries, they are well-networked but spread thin — a specialist contributor you invite for what they know, not for consortium-building capacity.
MSU has collaborated with 88 unique partners across 28 countries, indicating broad but shallow European connections typical of a US-based third-party contributor invited into diverse consortia for specialized expertise.
As one of the few US universities actively participating in H2020, MSU offers European consortia access to American research infrastructure, student talent pipelines, and scientific networks that most EU-only partnerships lack. Their particular strength in optogenetics and photobiology — bridging cyanobacterial biochemistry with neuroscience applications — is an unusual cross-disciplinary combination. For consortium builders needing a credible US partner with proven H2020 experience and MSCA fellowship hosting track record, MSU is a reliable and tested choice.
